Indication
Survivorship
1 clinical trial
1 product
Clinical trial
Bortezomib, Thalidomide, and Dexamethasone Versus Thalidomide and Dexamethasone for Response Rates in Multiple Myeloma Patients: a Retrospective StudyStatus: Recruiting, Estimated PCD: 2024-03-20
Product
Bortezomib